---
title: "NATA OPTO-ELECT: Vice President Chen Huabing resigns for personal reasons"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/250095474.md"
description: "On July 25th, NATA OPTO-ELECT announced that the company's board of directors recently received a written resignation letter from the company's vice president Chen Huabing, who applied to resign from the position of vice president for personal reasons and will no longer hold any position in the company after resigning. Chen Huabing's resignation will not affect the normal operations of the company, and the resignation letter will take effect from the date it is delivered to the company's board of directors"
datetime: "2025-07-25T08:15:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/250095474.md)
  - [en](https://longbridge.com/en/news/250095474.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/250095474.md)
generator: "portal-rs"
---

# NATA OPTO-ELECT: Vice President Chen Huabing resigns for personal reasons

On July 25th, NATA OPTO-ELECT announced that the company's board of directors recently received a written resignation letter from the company's Vice President Chen Huabing, who applied to resign from the position due to personal reasons and will no longer hold any position in the company after resigning. Chen Huabing's resignation will not affect the normal operation of the company, and the resignation letter will take effect from the date it is delivered to the company's board of directors

### Related Stocks

- [300346.CN](https://longbridge.com/en/quote/300346.CN.md)

## Related News & Research

- [Cupid share price in focus on board approval to set up manufacturing venture in South African](https://longbridge.com/en/news/297455298.md)
- [Solar Foods board member Jukka Moisio receives 5,102 shares under share-based incentive plan](https://longbridge.com/en/news/297510027.md)
- [Dato David Gurupatham & Koay Launches Cross-Border Dispute Practice in Jinan, China](https://longbridge.com/en/news/297503026.md)
- [Vale Indonesia schedules annual public expose webcast on quarterly performance and growth projects](https://longbridge.com/en/news/297146336.md)
- [Palvella completes rolling FDA NDA submission for QTORIN rapamycin in microcystic lymphatic malformations](https://longbridge.com/en/news/297509688.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**